Congenital Disorders of Glycosylation
Gene: PIGL
Glycosylphosphatidylinositol (GPI) is used as a membrane anchor by many eukaryotic cell surface proteins. The first step in GPI biosynthesis involves the transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI). The second step is N-deacetylation of GlcNAc-PI, which is performed by PIGL.
Bi-allelic variants in PIGL have been associated with a multisystem disorder clinically characterised by colobomas, congenital heart defects, migratory ichthyosiform dermatosis, mental retardation, and ear anomalies (CHIME). Other clinical features include distinctive facial features, abnormal growth, genitourinary abnormalities, seizures, and feeding difficulties. Some individuals have hyperphosphatasia.
p.Leu167Pro is a common founder variant. Also note large deletion reported more than once.
More than 10 unrelated families reported.Created: 19 Dec 2020, 6:32 a.m. | Last Modified: 19 Dec 2020, 6:32 a.m.
Panel Version: 0.270
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
CHIME syndrome, MIM# 280000, MONDO:0010221
Publications
Gene: pigl has been classified as Green List (High Evidence).
Tag SV/CNV tag was added to gene: PIGL. Tag founder tag was added to gene: PIGL.
Phenotypes for gene: PIGL were changed from to CHIME syndrome, MIM# 280000, MONDO:0010221
Publications for gene: PIGL were set to
Mode of inheritance for gene: PIGL was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: PIGL was added gene: PIGL was added to Congenital Disorders of Glycosylation_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: PIGL was set to Unknown